Open original FDA record ↗Recall record
- FDA identifier
- Z-1448-2020
- Company in FDA record
- Biofire Defense
- FDA classification date
- Feb 18, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
The firm has identified that an incorrect instruction for use (IFU) revision was included in the qualitative, multiplexed, nucleic acid-based in vitro diagnostic test kit.
Source facts
- Action
- On 8/20/2019, a "Urgent: Customer Recall Notice" letter was sent to all affected consignees informing them on the recall. In addition to providing information on the recall, the firm asked consignees do the following: 1. BFDf has enclosed a replacement printed copy of the Revision 02 Warrior IFU with this notice. BFDf advises customers to remove and dispose of all incorrect IFUs included in non-expired product from the affected lots listed. BFDf will provide additional replacement copies of the IFU on request. 2. Please complete and return the accompanying Recall Acknowledgement of Receipt Form included with this Notice, using one of the listed methods to confirm your receipt of this notification. 3. If you have any additional questions or concerns, please do not hesitate to contact BFDf Customer Support via email at Support@biofiredefense.com or via telephone at 1-801-262-3592 for product technical support.
- Initiated
- 2019-08-20
- Root cause
- Labeling Change Control
- Terminated
- 2020-10-30
- Distribution
- US: UT, MD, GA, CO, OH, TX, OUS: None
- Recall number
- Z-1448-2020
- Recall status
- Terminated
- CDRH record ID
- 179616
- FDA classified
- 2020-02-18
- Recall event number
- 84887